new
   How to Purchase Nelarabine (Atriance)
502
Oct 28, 2025

Nelarabine (Atriance) is an intravenous medication used to treat relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). Due to its specific indications and potential severe neurotoxicity (such as coma, seizures, etc.), its purchase and use must strictly follow medical guidance.

How to Purchase Nelarabine (Atriance)

Overseas Purchase

Patients may choose to consult and purchase nelarabine at hospital pharmacies or licensed drugstores in countries or regions where the drug has been launched.

Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.

Purchase Through Medical Service Institutions

Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions usually provide legal import channels and can offer professional consultation and guidance.

Precautions for Purchasing Nelarabine (Atriance)

Strictly Follow Doctor’s Instructions

The adult dose is 1500mg/m² (intravenous infusion on Days 1, 3, and 5), and the pediatric dose is 650mg/m² (continuous infusion for 5 days). The dose must be calculated based on body weight and body surface area.

The medication must be administered on an empty stomach (fasting for 1 hour before infusion or 2 hours after infusion) to avoid affecting its efficacy.

Monitor for Neurotoxicity

Nelarabine may cause severe neurological adverse reactions (such as peripheral neuropathy, drowsiness, seizures).

If symptoms such as numbness in hands and feet, difficulty walking, or confusion occur, discontinue the medication immediately and seek medical attention.

Contraindications and Drug Interactions

Concomitant use with adenosine deaminase inhibitors (e.g., pentostatin) should be avoided, as this may reduce the efficacy of nelarabine.

The drug is contraindicated in pregnant women, and patients of childbearing age must use effective contraceptive measures.

Cold Chain and Storage Requirements

Nelarabine should be stored at 20°C–25°C, and its transportation must comply with cold chain standards.

When purchasing, check whether the packaging is intact and whether there is a temperature recording label.

How to Identify the Authenticity of Nelarabine (Atriance)

Packaging and Label Verification

Original packaging: Authentic products come in 250mg/50mL single-dose glass vials, with gray bromobutyl rubber stoppers and aluminum seals with pull-tab design.

Label information: It must include the NDC code (e.g., 66758-165-94), batch number, expiration date, and Novartis/Sandoz manufacturer logo.

Medication Characteristic Inspection

Solution appearance: Authentic solutions are colorless and transparent, with no suspended matter or sediment. Any turbidity, discoloration, or particulate matter indicates an abnormality.

Vial labeling: The vial should be clearly marked with "ARRANON® (nelarabine) injection" and concentration (5mg/mL).

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Dosage and Administration, Recommended Dose of Elacestrant (Orserdu)

Elacestrant (Orserdu) is a selective estrogen receptor degrader (SERD), which provides an important treatment option...

Friday, December 19th, 2025, 11:49
What Are the Indications for Elacestrant (Orserdu)?

Elacestrant (Orserdu) is a novel endocrine therapy agent that demonstrates significant value in the treatment of...

Friday, December 19th, 2025, 11:40
What Are the Purchase Channels for Elacestrant (Orserdu)?

With the advancement of medical technology, elacestrant (Orserdu), a targeted drug for breast cancer with specific...

Friday, December 19th, 2025, 11:38
Adverse Reactions of Capmatinib (Tabrecta)

Capmatinib (Tabrecta) is a highly selective MET inhibitor indicated for the treatment of patients with advanced...

Friday, December 19th, 2025, 11:35
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved